Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Japan Tissue Engineering Co stock

7774.T
JP3389610001

Price

503.00
Today +/-
-0.01
Today %
-0.40 %
P

Japan Tissue Engineering Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Japan Tissue Engineering Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Japan Tissue Engineering Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Japan Tissue Engineering Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Japan Tissue Engineering Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Japan Tissue Engineering Co Stock Price History

DateJapan Tissue Engineering Co Price
11/8/2024503.00 undefined
11/7/2024505.00 undefined
11/6/2024505.00 undefined
11/5/2024503.00 undefined
11/1/2024500.00 undefined
10/31/2024502.00 undefined
10/30/2024501.00 undefined
10/29/2024505.00 undefined
10/28/2024490.00 undefined
10/25/2024490.00 undefined
10/24/2024495.00 undefined
10/23/2024504.00 undefined
10/22/2024504.00 undefined
10/21/2024514.00 undefined
10/18/2024513.00 undefined
10/17/2024517.00 undefined
10/16/2024519.00 undefined
10/15/2024520.00 undefined
10/11/2024523.00 undefined

Japan Tissue Engineering Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Japan Tissue Engineering Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Japan Tissue Engineering Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Japan Tissue Engineering Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Japan Tissue Engineering Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Japan Tissue Engineering Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Japan Tissue Engineering Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Japan Tissue Engineering Co’s growth potential.

Japan Tissue Engineering Co Revenue, EBIT and net profit per share

DateJapan Tissue Engineering Co RevenueJapan Tissue Engineering Co EBITJapan Tissue Engineering Co Net Income
2027e5.1 B undefined0 undefined1.14 B undefined
2026e3.93 B undefined0 undefined594.73 M undefined
2025e2.97 B undefined0 undefined143.56 M undefined
20242.51 B undefined144.51 M undefined143.17 M undefined
20232.03 B undefined-728.12 M undefined-729.32 M undefined
20222.1 B undefined-498.18 M undefined-497.89 M undefined
20212.26 B undefined-466.86 M undefined-466.62 M undefined
20202.31 B undefined-235.18 M undefined-287.1 M undefined
20192.36 B undefined-349.75 M undefined-333.25 M undefined
20182.27 B undefined211.51 M undefined227.89 M undefined
20172.14 B undefined312.39 M undefined276.24 M undefined
20161.43 B undefined-722.6 M undefined-681.54 M undefined
20151.32 B undefined-688.02 M undefined-690.53 M undefined
20141.01 B undefined-1.03 B undefined-827.8 M undefined
2013563.7 M undefined-1.1 B undefined-1.08 B undefined
2012473.6 M undefined-1.11 B undefined-1.1 B undefined
2011351.6 M undefined-1.15 B undefined-1.16 B undefined
2010211.7 M undefined-1.07 B undefined-1.1 B undefined
2009114.7 M undefined-1.1 B undefined-1.13 B undefined
2008111.8 M undefined-1.07 B undefined-1.09 B undefined
2007103.4 M undefined-973.8 M undefined-916.4 M undefined
200668.9 M undefined-810.2 M undefined-690.6 M undefined
200540.5 M undefined-712.3 M undefined-578 M undefined

Japan Tissue Engineering Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
000.040.070.10.110.110.210.350.470.561.011.321.432.142.272.362.312.262.12.032.512.973.935.1
---70.0051.477.772.7085.0966.3534.7619.0379.0431.058.2549.306.373.79-2.04-2.25-6.82-3.3823.7218.1032.3329.70
--2.50-14.71-10.689.918.777.58-3.1314.5924.6947.1239.8940.4257.3359.5854.4851.4551.2259.6855.9167.22---
000-0.01-0.010.010.010.02-0.010.070.140.480.530.581.221.351.281.191.161.261.141.69000
-505-537-712-810-973-1,071-1,102-1,067-1,145-1,107-1,103-1,025-688-722312211-349-235-466-498-728144000
---1,780.00-1,191.18-944.66-964.86-966.67-505.69-326.21-234.04-195.91-101.69-52.08-50.4914.619.29-14.81-10.18-20.65-23.68-35.835.73---
-0.48-0.5-0.58-0.69-0.92-1.09-1.13-1.1-1.16-1.1-1.08-0.83-0.69-0.680.280.23-0.33-0.29-0.47-0.5-0.730.140.140.591.14
-4.3815.3719.3832.7518.564.42-3.095.28-5.27-1.73-23.21-16.57-1.30-140.53-17.75-246.70-13.8162.376.6546.68-119.62-315.3892.59
20.220.220.220.220.216.620.220.427.836.636.636.737.9240.5840.5940.6140.6140.6140.6140.6140.6140.61000
-------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Japan Tissue Engineering Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Japan Tissue Engineering Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                           
0.210.941.640.852.53.042.221.484.182.861.611.315.973.854.096.25.935.755.284.934.134.27
0042.57.718.19.120.94272.898.8115.7370.7371.05405.83788.09543.04641.43594.63769.66406.93576.03604.29
5.51687.110.900.90.11.25.230.945.898.632.4648.5245.3948.0892.3786.9752.7989.560.24.37
9.426.720.826.436.736.739.987.858.263.771.3107138.01123.22105.15135.19146.27166.04204.07187.29237.62228.57
7.819.522.273.936.925.226.638.437.337.433.830.5165.1970.0842.03163.94214.52218.32242.21328.84262.94235.71
0.2411.810.972.593.112.31.644.363.091.871.916.674.55.077.097.026.826.545.955.215.34
0.150.421.491.371.261.181.091.51.421.361.31.261.71.821.731.661.651.621.561.611.571.51
00000000000020202020202020202020
0000000000000000000000
0.80.72.32.22.28.136.442.536.129.928.747.548.348.5437.8323.0418.5810.0116.5836.2793.58102.53
0000000000000000000000
0.020.010.020.020.020.030.030.010.020.020.010.010.431.921.710.250.060000.010.04
0.170.431.511.391.281.221.151.551.481.411.341.322.183.793.481.931.731.631.571.651.671.65
0.41.433.322.363.874.333.453.25.834.493.213.238.858.38.559.028.758.458.127.66.886.99
                                           
1.12.173.443.444.165.545.555.727.727.727.727.7911.5211.524.954.964.964.964.964.964.964.96
001.271.271.993.373.383.555.555.555.555.629.359.352.782.792.792.792.792.792.792.79
-1,611.1-2,113.1-2,691.1-3,381.7-4,298.2-5,384.4-6,518.4-7,618.3-8,775.3-9,871.7-10,949.4-11,237.2-12,467.73-13,149.27276.24504.13170.88-116.22-582.84-1,080.73-1,810.05-1,666.88
0000000000000-00000-0-0-0-0
0000000000000000000000
-0.510.062.021.331.863.532.421.644.493.392.332.168.47.728.018.257.927.637.166.675.946.08
11.78.721.422.623.135.52539.435.928.439.3103.839.4556.3848.8573.8490.42119.81147.47117.09135.9283.59
20.425.626.729.440.747.445.24853.765.765.281.588.8988.3294.3104.31143.77155.41160.77151.5151.86181.44
35.485.1142154.516399.1134.4109.5138.7141.5165.4230.7209.89337.8348.62550.69558.52507.38609.91627.23623.34608.51
00.30.1901.100000000000000000
40.396.796.796.796.796.796.7239.7244.5251.3207.8125.57.947.666.6653.21.370.870.80.130
0.110.520.480.31.420.280.30.440.470.490.480.540.350.490.50.730.80.780.920.90.910.87
0.760.820.730.630.530.440.641.010.760.520.310.440.020.010.010000000
0000000000000000000000
41.331.596.194.160.98195.1110.9106.893.991.291.291.273.734.934.934.934.934.934.934.934.9
0.810.850.820.720.590.520.731.120.870.620.410.530.110.090.040.040.040.040.040.040.030.03
0.911.371.31.032.020.791.031.561.341.10.881.070.460.580.540.770.830.820.950.930.950.91
0.41.433.322.363.874.333.453.25.834.493.213.238.858.38.559.028.758.458.127.66.886.99
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Japan Tissue Engineering Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Japan Tissue Engineering Co's financial health and stability.

Assets

Japan Tissue Engineering Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Japan Tissue Engineering Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Japan Tissue Engineering Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Japan Tissue Engineering Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
-501-577-688-912-1,082-1,130-1,096-1,153-1,092-1,073-824-686-677309213-339-229-462-494-725
367813712310510211410695868886136112116119124128124131
00000000000000000000
-5224-37-62-13-853-83-14-250-173217-329300-20714-66154-28
18-65-71515718463021122416-22-3823161-100
1417184419112727181311000000000
111244233333345113-8333
-451-561-597-775-981-1,021-1,021-1,012-1,059-990-961-756-34654632-396-84-399-225-622
-2-1,273-208-13-21-20-560-25-22-18-34-524-260-23-31-72-91-74-117-175
-0-1.810.020.06-1.921.080.24-0.910.480.480.31-1.43-2.96-0.02-0.430.030.210.13-0.121.12
0-0.540.220.07-1.91.10.81-0.880.50.50.34-0.9-2.70-0.40.10.30.201.3
00000000000000000000
0.11-0.1-0.11-1.20.20.51-0.24-0.25-0.250.03-0.56-0.01-0.01-0.01-0.01-0-000
1.062.5301.442.740.020.323.9900.010.126.900.010.0200000
1.182.43-0.12.441.540.220.833.75-0.25-0.240.76.34-0.0100.01-0.01-0-000
0000000000540000000000
00000000000000000000
0.720.06-0.681.72-1.360.280.061.83-0.83-0.750.044.16-3.310.040.21-0.370.12-0.28-0.340.5
-453.4-1,835.2-806.2-789.1-1,003.1-1,042.5-1,581.4-1,037.9-1,081.4-1,008.7-995.7-1,281.25-607.2231.21600.01-469.08-175.82-473.98-342.48-798.6
00000000000000000000

Japan Tissue Engineering Co stock margins

The Japan Tissue Engineering Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Japan Tissue Engineering Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Japan Tissue Engineering Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Japan Tissue Engineering Co's sales revenue. A higher gross margin percentage indicates that the Japan Tissue Engineering Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Japan Tissue Engineering Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Japan Tissue Engineering Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Japan Tissue Engineering Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Japan Tissue Engineering Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Japan Tissue Engineering Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Japan Tissue Engineering Co Margin History

Japan Tissue Engineering Co Gross marginJapan Tissue Engineering Co Profit marginJapan Tissue Engineering Co EBIT marginJapan Tissue Engineering Co Profit margin
2027e67.24 %0 %22.46 %
2026e67.24 %0 %15.13 %
2025e67.24 %0 %4.83 %
202467.24 %5.75 %5.69 %
202355.92 %-35.82 %-35.88 %
202259.69 %-23.68 %-23.67 %
202151.25 %-20.68 %-20.67 %
202051.44 %-10.18 %-12.43 %
201954.49 %-14.83 %-14.13 %
201859.59 %9.31 %10.03 %
201757.33 %14.63 %12.94 %
201640.46 %-50.5 %-47.63 %
201539.92 %-52.06 %-52.25 %
201447.16 %-101.73 %-82.12 %
201324.73 %-195.69 %-191.18 %
201214.74 %-233.83 %-231.5 %
2011-3.27 %-325.8 %-329.07 %
20107.7 %-504.2 %-519.56 %
20099.33 %-961.29 %-988.67 %
200810.64 %-958.59 %-971.56 %
2007-10.64 %-941.78 %-886.27 %
2006-15.24 %-1,175.91 %-1,002.32 %
20052.96 %-1,758.77 %-1,427.16 %

Japan Tissue Engineering Co Stock Sales Revenue, EBIT, Earnings per Share

The Japan Tissue Engineering Co earnings per share therefore indicates how much revenue Japan Tissue Engineering Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Japan Tissue Engineering Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Japan Tissue Engineering Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Japan Tissue Engineering Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Japan Tissue Engineering Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Japan Tissue Engineering Co Revenue, EBIT and net profit per share

DateJapan Tissue Engineering Co Sales per ShareJapan Tissue Engineering Co EBIT per shareJapan Tissue Engineering Co Earnings per Share
2027e125.49 undefined0 undefined28.18 undefined
2026e96.77 undefined0 undefined14.65 undefined
2025e73.13 undefined0 undefined3.54 undefined
202461.91 undefined3.56 undefined3.53 undefined
202350.05 undefined-17.93 undefined-17.96 undefined
202251.8 undefined-12.27 undefined-12.26 undefined
202155.59 undefined-11.5 undefined-11.49 undefined
202056.88 undefined-5.79 undefined-7.07 undefined
201958.06 undefined-8.61 undefined-8.21 undefined
201855.94 undefined5.21 undefined5.61 undefined
201752.6 undefined7.7 undefined6.81 undefined
201635.26 undefined-17.81 undefined-16.79 undefined
201534.85 undefined-18.15 undefined-18.21 undefined
201427.47 undefined-27.94 undefined-22.56 undefined
201315.4 undefined-30.14 undefined-29.45 undefined
201212.94 undefined-30.26 undefined-29.96 undefined
201112.65 undefined-41.21 undefined-41.62 undefined
201010.38 undefined-52.32 undefined-53.92 undefined
20095.68 undefined-54.58 undefined-56.14 undefined
20086.73 undefined-64.56 undefined-65.43 undefined
20075.12 undefined-48.21 undefined-45.37 undefined
20063.41 undefined-40.11 undefined-34.19 undefined
20052 undefined-35.26 undefined-28.61 undefined

Japan Tissue Engineering Co business model

Japan Tissue Engineering Co is one of the most popular companies on Eulerpool.com.

Japan Tissue Engineering Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Japan Tissue Engineering Co historical P/E ratio, EBIT multiple, and P/S ratio

Japan Tissue Engineering Co shares outstanding

The number of shares was Japan Tissue Engineering Co in 2023 — This indicates how many shares 40.61 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Japan Tissue Engineering Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Japan Tissue Engineering Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Japan Tissue Engineering Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Japan Tissue Engineering Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Japan Tissue Engineering Co stock splits

In Japan Tissue Engineering Co's history, there have been no stock splits.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Japan Tissue Engineering Co.

Japan Tissue Engineering Co shareholders

%
Name
Stocks
Change
Date
57.71781 % Teijin Ltd23,439,17303/31/2024
10.40927 % Nidek Co., Ltd.4,227,20003/31/2024
0.84314 % Maeda (Yoko)342,40003/31/2024
0.71904 % Ozawa (Yosuke)292,00003/31/2024
0.71411 % Gomi (Daisuke)290,00003/31/2024
0.69117 % SBI Securities Co., Ltd.280,68546,1873/31/2024
0.58651 % Japan Tissue Engineering Co., Ltd. Employees238,1831,0003/31/2024
0.45309 % Sala Energy Co Ltd184,00003/31/2024
0.41098 % Ueda Yagi Tanshi Co., Ltd.166,900-100,0003/31/2024
0.17927 % Simplex Asset Management Co., Ltd.72,80009/30/2024
1
2

Japan Tissue Engineering Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
CellSeed Stock
CellSeed
SupplierCustomer0,53-0,250,540,810,940,62
FUJIFILM Holdings Stock
FUJIFILM Holdings
SupplierCustomer0,07 0,420,700,53-0,17
1

Most common questions regarding Japan Tissue Engineering Co

What is the P/E ratio of Japan Tissue Engineering Co 2024?

The Japan Tissue Engineering Co P/E ratio is 142.68.

What is the P/S ratio of Japan Tissue Engineering Co 2024?

The Japan Tissue Engineering Co P/S ratio is 8.12.

What is the Quality Investing of Japan Tissue Engineering Co?

The Quality Investing for Japan Tissue Engineering Co is 3/10.

What is the revenue of Japan Tissue Engineering Co 2024?

The Japan Tissue Engineering Co revenue is 2.51 B JPY.

How high is the profit of Japan Tissue Engineering Co 2024?

The Japan Tissue Engineering Co profit is 143.17 M JPY.

What is the business model of Japan Tissue Engineering Co

No history available for Japan Tissue Engineering Co.

What is the Japan Tissue Engineering Co dividend?

Japan Tissue Engineering Co pays a dividend of 0 JPY distributed over payouts per year.

How often does Japan Tissue Engineering Co pay dividends?

The dividend cannot currently be calculated for Japan Tissue Engineering Co or the company does not pay out a dividend.

What is the Japan Tissue Engineering Co ISIN?

The ISIN of Japan Tissue Engineering Co is JP3389610001.

What is the Japan Tissue Engineering Co ticker?

The ticker of Japan Tissue Engineering Co is 7774.T.

How much dividend does Japan Tissue Engineering Co pay?

Over the past 12 months, Japan Tissue Engineering Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Japan Tissue Engineering Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of Japan Tissue Engineering Co?

The current dividend yield of Japan Tissue Engineering Co is .

When does Japan Tissue Engineering Co pay dividends?

Japan Tissue Engineering Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Japan Tissue Engineering Co?

Japan Tissue Engineering Co paid dividends every year for the past 0 years.

What is the dividend of Japan Tissue Engineering Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Japan Tissue Engineering Co located?

Japan Tissue Engineering Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Japan Tissue Engineering Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Japan Tissue Engineering Co from 11/9/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Japan Tissue Engineering Co pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Japan Tissue Engineering Co in the year 2023?

In the year 2023, Japan Tissue Engineering Co distributed 0 JPY as dividends.

In which currency does Japan Tissue Engineering Co pay out the dividend?

The dividends of Japan Tissue Engineering Co are distributed in JPY.

All fundamentals about Japan Tissue Engineering Co

Our stock analysis for Japan Tissue Engineering Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Japan Tissue Engineering Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.